Compounds > vx 497
Page last updated: 2024-09-04

vx 497 and benzoic acid [5-amino-1-(4-methoxyphenyl)sulfonyl-3-pyrazolyl] ester

vx 497 has been researched along with benzoic acid [5-amino-1-(4-methoxyphenyl)sulfonyl-3-pyrazolyl] ester in 1 studies

Compound Research Comparison

Studies
(vx 497)		Trials
(vx 497)		Recent Studies (post-2010)
(vx 497)		Studies
(benzoic acid [5-amino-1-(4-methoxyphenyl)sulfonyl-3-pyrazolyl] ester)		Trials
(benzoic acid [5-amino-1-(4-methoxyphenyl)sulfonyl-3-pyrazolyl] ester)		Recent Studies (post-2010) (benzoic acid [5-amino-1-(4-methoxyphenyl)sulfonyl-3-pyrazolyl] ester)
2537802

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)benzoic acid [5-amino-1-(4-methoxyphenyl)sulfonyl-3-pyrazolyl] ester (IC50)
Genome polyprotein Zika virus1.5
Cathepsin GHomo sapiens (human)20.8178
Cathepsin BHomo sapiens (human)9.5626
kallikrein-5 preproproteinHomo sapiens (human)2.5418
Genome polyproteinWest Nile virus0.105

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT1

Reviews

1 review(s) available for vx 497 and benzoic acid [5-amino-1-(4-methoxyphenyl)sulfonyl-3-pyrazolyl] ester

ArticleYear
Drugs for the Treatment of Zika Virus Infection.
    Journal of medicinal chemistry, 2020, 01-23, Volume: 63, Issue:2

    Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection

2020